Expertise, preventive care important to stop ovarian cancer
You've heard the saying, "If it isn't broke, don't fix it."
Sep 10, 2014
0
0
You've heard the saying, "If it isn't broke, don't fix it."
Sep 10, 2014
0
0
Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...
Aug 26, 2013
0
0
This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.
Apr 25, 2013
0
0
Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...
Feb 14, 2013
0
0
the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included ...
Jan 14, 2013
0
0
Women who have surgery for ovarian cancer have better outcomes if they are treated at high-volume hospitals, according to researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University ...
Nov 20, 2012
0
0
A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests ...
Nov 8, 2012
0
0
(HealthDay)—A leading U.S. government panel has recommended against ovarian cancer screening for women who are not at high risk for the disease.
Sep 10, 2012
0
0
Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is ...
Jan 20, 2012
0
0
Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.
Sep 6, 2011
0
0